Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C.
Rongioletti
F
F
Department of Dermatology, University of Genoa, Italy.
Rebora
A
A
D000423:Alcian Blue; D000998:Antiviral Agents / Q000009:adverse effects*; D001706:Biopsy; D004396:Coloring Agents; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D017512:Lichenoid Eruptions / Q000473:pathology / Q000503:physiopathology*; D008875:Middle Aged; D017520:Mucinoses; D009230:Myxedema; D011994:Recombinant Proteins
D000998:Antiviral Agents; D004396:Coloring Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D000423:Alcian Blue